A PHASE I/II STUDY OF ADOPTIVE T-CELL THERAPY (ALT) AND DC VACCINATION (DCV) DURING RECOVERY FROM MYELOABLATIVE CHEMOTHERAPY AND HEMATOPOIETIC STEM CELL TRANSPLANTATION (HDC plus ASCR) OR NON-MYELOABLATIVE CONDITIONING (NMA) IN PATIENTS (PTS) WITH RECURRENT CENTRAL PNETS (RE-MATCH PROTOCOL)

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Gururangan, S; Grant, G; Driscoll, T; Archer, G; Herndon, J; Friedman, H; Kurtzberg, J; Bigner, D; Sampson, J; Mitchell, D

Published Date

  • April 1, 2013

Published In

Volume / Issue

  • 15 /

Start / End Page

  • 46 - 47

Published By

Pages

  • 2

International Standard Serial Number (ISSN)

  • 1522-8517

Conference Name

  • 2nd Annual Pediatric Neuro-Oncology Basic and Translational Research Conference

Conference Location

  • Fort Lauderdale, FL

Conference Start Date

  • May 16, 2013

Conference End Date

  • May 17, 2013